Assets Alterar Data
Agios Pharmaceuticals USD 937.12M 70.14M 2023-12
ALKERMES USD 2.28B 92.05M 2023-09
Alterity Therapeutics Limited AUD 27.32M 6.07M 2023-06
Amgen USD 97.15B 6.62B 2023-12
Baxter International USD 28.28B 2.38B 2023-12
BioCryst Pharmaceuticals USD 522.92M 6.96M 2023-09
Biogen USD 26.84B 1.35B 2023-12
Bluebird Bio USD 613.61M 49.78M 2023-09
Bristol-Myers Squibb USD 91.26B 2.23B 2023-09
Cara Therapeutics USD 115.34M 19.05M 2023-09
Eisai JPY 1.33T 28.9B 2023-09
Eli Lilly USD 57.92B 3.1B 2023-09
Esperion Therapeutics USD 221.3M 13.32M 2023-09
Exelixis USD 2.98B 165.56M 2023-09
Gilead Sciences USD 62.13B 248M 2023-12
GlaxoSmithKline GBP 60.86B 1.4B 2023-09
Grifols EUR 22.06B 631.75M 2023-09
Halozyme Therapeutics USD 1.73B 159.39M 2023-12
Incyte USD 6.78B 393.87M 2023-12
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
Ironwood Pharmaceuticals USD 471.07M 52.99M 2023-12
Merck USD 106.73B 2.26B 2023-09
Nektar Therapeutics USD 442.24M 52.04M 2023-09
Neurocrine Biosciences USD 2.85B 235.1M 2023-09
Pfizer USD 215.02B 5.15B 2023-09
Roche Holding CHF 84.37B 3.78B 2023-06
Sarepta Therapeutics USD 3.11B 16.18M 2023-09
Takeda JPY 14.87T 79.15B 2023-09
Teva Pharmaceutical Industries USD 42.09B 1.01B 2023-09
Xencor USD 952.69M 174.26M 2023-12



Nektar Therapeutics Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.